Magrath George has filed 17 insider transactions across 1 company since November 2023.
Most recent transaction: a sale of 24438 shares of Opus Genetics, Inc. ($IRD) on March 16, 2026.
Activity breakdown: 5 open-market purchases and 1 sale.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 16, 2026 | Opus Genetics, Inc. | $IRD | Magrath George | Chief Executive Officer | S | Common Stock | 24438 | $5.21 | 1,750,855.0000 | 70,636,887 | 1.38% | 0.03% |
| Jan. 22, 2026 | Opus Genetics, Inc. | $IRD | Magrath George | Chief Executive Officer | A | Common Stock | 483639 | $0.00 | 1,775,293.0000 | 70,636,887 | 37.44% | 0.68% |
| Nov. 1, 2025 | Opus Genetics, Inc. | $IRD | Magrath George | Chief Executive Officer | F | Common Stock | 30350 | $2.30 | 1,291,654.0000 | 70,636,887 | 2.30% | 0.04% |
| Nov. 1, 2025 | Opus Genetics, Inc. | $IRD | Magrath George | Chief Executive Officer | F | Common Stock | 30350 | $2.30 | 1,291,654.0000 | 70,636,887 | 2.30% | 0.04% |
| March 24, 2025 | Opus Genetics, Inc. | $IRD | Magrath George | Chief Executive Officer | A | Common Stock | 392157 | $0.00 | 1,322,004.0000 | 26,715,526 | 42.17% | 1.47% |
| March 24, 2025 | Opus Genetics, Inc. | $IRD | Magrath George | Chief Executive Officer | A | Warrants (right to buy) | 392157 | $0.00 | 392,157.0000 | 26,715,526 | 9999.99% | 1.47% |
| March 13, 2025 | Opus Genetics, Inc. | $IRD | Magrath George | Chief Executive Officer | A | Common Stock | 330697 | $0.00 | 929,847.0000 | 26,715,526 | 55.19% | 1.24% |
| March 13, 2025 | Opus Genetics, Inc. | $IRD | Magrath George | Chief Executive Officer | A | Employee Stock Option (right to buy) | 330697 | $0.00 | 330,697.0000 | 26,715,526 | 9999.99% | 1.24% |
| Dec. 26, 2024 | Opus Genetics, Inc. | $IRD | Magrath George | Chief Executive Officer | P | Common Stock | 100000 | $0.98 | 599,150.0000 | 26,145,080 | 20.03% | 0.38% |
| Dec. 23, 2024 | Opus Genetics, Inc. | $IRD | Magrath George | Chief Executive Officer | A | Common Stock | 6200 | $0.00 | 499,150.0000 | 26,145,080 | 1.26% | 0.02% |
| Nov. 18, 2024 | Opus Genetics, Inc. | $IRD | Magrath George | Chief Executive Officer | P | Common Stock | 9706 | $1.02 | 492,950.0000 | 26,145,080 | 2.01% | 0.04% |
| Nov. 15, 2024 | Opus Genetics, Inc. | $IRD | Magrath George | Chief Executive Officer | P | Common Stock | 90294 | $1.01 | 483,244.0000 | 26,145,080 | 22.98% | 0.35% |
| Nov. 1, 2024 | Opus Genetics, Inc. | $IRD | Magrath George | Chief Executive Officer | F | Common Stock | 37050 | $1.18 | 392,950.0000 | 26,145,080 | 8.62% | 0.14% |
| May 17, 2024 | Opus Genetics, Inc. | $IRD | Magrath George | Chief Executive Officer | P | Common Stock | 5000 | $1.75 | 430,000.0000 | 21,589,821 | 1.18% | 0.02% |
| March 18, 2024 | Opus Genetics, Inc. | $IRD | Magrath George | Chief Executive Officer | P | Common Stock | 25000 | $1.96 | 425,000.0000 | 21,589,821 | 6.25% | 0.12% |
| Nov. 1, 2023 | Opus Genetics, Inc. | $IRD | Magrath George | Chief Executive Officer | A | Employee Stock Option (right to buy) | 600000 | $0.00 | 600,000.0000 | 0 | 9999.99% | 0.00% |
| Nov. 1, 2023 | Opus Genetics, Inc. | $IRD | Magrath George | Chief Executive Officer | A | Common Stock | 400000 | $0.00 | 400,000.0000 | 0 | 9999.99% | 0.00% |